Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  American Journal of Tropical Medicine and Hygiene

• Publication date

  1984-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4269/AJTMH.1984.33.511PMID 6731683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• NITAZOXANIDE FOR ENTEROCYTOZOON BIENEUSI INFECTION TREATMENT IN RENAL TRANSPLANT RECIPIENTS: CASE SERIES

  2026cites this paper
• Evaluation of the therapeutic efficacy of albendazole and nitazoxanide loaded chitosan nanoparticles against experimental echinococcosis

  2025cites this paper
• Evaluation of the pharmacological efficacy and potential of nitazoxanide, a broad–spectrum thiazolide drug

  2024cites this paper
• Glucuronidation of tizoxanide, an active metabolite of nitazoxanide, in liver and small intestine: Species differences in humans, monkeys, dogs, rats, and mice and responsible UDP-glucuronosyltransferase isoforms in humans.

  2024cites this paper
• Joint Screening and Identification of Potential Targets of Nitazoxanide by Affinity Chromatography and Label-Free Techniques.

  2024cites this paper
• Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome.

  2024cites this paper
• Differences of Appearance, Life Cycle, Symptoms, Diagnose and Treatment Mmong Taenia Solium, Taenia Saginata and Taenia Asiatica

  2023cites this paper
• A Turn-On–Type Fluorescence Resonance Energy Transfer Eco-friendly Method for Nitazoxanide Quantification in Pharmaceutical Dosage Form and Spiked Plasma: Evaluation of Greenness Profile Using Different Assessment Tools

  2022cites this paper
• Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells

  2022cites this paper
• Current Therapy and Therapeutic Targets for Microsporidiosis

  2022cites this paper
• Why medicines work.

  2022cites this paper
• Synthesis, antiviral activity, preliminary pharmacokinetics and structural parameters of thiazolide amine salts.

  2021cites this paper
• Microsporidiosis in Humans

  2021cites this paper
• Nitazoxanide induced myocardial injury in zebrafish embryos by activating oxidative stress response

  2021cites this paper
• The role of antiparasitc drugs and steroids in Covid-19 treatment

  2021cites this paper
• Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer.

  2021cites this paper
• Nitazoxanida: aspectos gerais, sistemas de liberação e potencial de reposicionamento da molécula

  2021cites this paper
• Quantitative proteomic analysis of the tizoxanide effect in vero cells

  2020cites this paper
• Scientists’ pursuit for SARS-COV-2 coronavirus: strategies against pandemic

  2020cites this paper
• PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS

  2020cites this paper
• Broad-spectrum therapeutics: A new antimicrobial class

  2020cites this paper
• SCIENTIST’S PURSUIT FOR CORONAVIRUS SARS-COV-2, WHICH CAUSES COVID-19: SCIENTIFIC STRATEGIES AGAINST PANDEMIC

  2020cites this paper
• JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis

  2020cites this paper
• Phenotypic screening techniques for Cryptosporidium drug discovery

  2020cites this paper
• Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain

  2019cites this paper
• Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.

  2019cites this paper
• Repurposing host-based therapeutics to control coronavirus and influenza virus

  2019cites this paper
• In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.

  2018cites this paper
• Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study

  2017cites this paper
• Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.

  2017cites this paper
• Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds

  2017cites this paper
• New preclinical strategies for characterization and development of anticancer drugs

  2017cites this paper
• Pharmaceutical Industry Performance

  2017cites this paper
• EPIDEMIOLOGY, MOLECULAR DETECTION, ZOONOTIC POTENTIAL, HEAMATOLOGY AND CHEMOTHERAPY OF CRYPTOSPORIDIOSIS IN SMALL RUMINANTS IN SOUTHERN KHYBER PAKHTUNKHWA, PAKISTAN

  2017cites this paper
• Quantitative structure activity relationship (QSAR) studies on nitazoxanide-based analogues against Clostridium difficile In vitro.

  2016cites this paper
• Nitazoxanide induces in vitro metabolic acidosis in Taenia crassiceps cysticerci.

  2016cites this paper
• Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugs

  2016cites this paper
• Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis.

  2016cites this paper
• Comparative parasitological and electron microscopic studies on the effects of Nitazoxanide and Praziquantel in Schistosoma mansoni-infected mice

  2016cites this paper
• Insights into the structure and inhibition of Giardia intestinalis arginine deiminase: homology modeling, docking, and molecular dynamics studies

  2016cites this paper
• Diversity of Fascioloides magna and Fasciola hepatica in Austria based on their genes and antigens

  2016cites this paper
• Evaluation of sugar floatation technique for diagnosis of gastro-intestinal parasites and its evaluation as epidemiological tool for the study of Hymenolepis nana

  2015cites this paper
• Repurposing drugs for the treatment and control of helminth infections

  2014cites this paper
• SUBCUTANEOUS CYSTICERCOSIS: ROLE OF HIGH RESOLUTION ULTRASOUND IN DIAGNOSIS

  2014cites this paper
• Nitazoxanide: nematicidal mode of action and drug combination studies.

  2014cites this paper
• Nitazoxanide Cocrystals in Combination with Succinic, Glutaric, and 2,5-Dihydroxybenzoic Acid

  2014cites this paper
• The discovery of medicines for rare diseases.

  2014cites this paper
• Nitazoxanide: A first-in-class broad-spectrum antiviral agent

  2014cites this paper
• caus-Current therapeutic approaches to equine protozoal myeloencephalitis

  2013cites this paper
• Synthesis and antiprotozoal activity of nitazoxanide-N-methylbenzimidazole hybrids.

  2013cites this paper
• Current therapeutic approaches to equine protozoal myeloencephalitis.

  2013cites this paper
• The Contribution of Mechanistic Understanding to Phenotypic Screening for First-in-Class Medicines

  2013cites this paper
• Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis

  2012cites this paper
• Current treatment options for Dientamoeba fragilis infections.

  2012cites this paper
• Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model.

  2012cites this paper
• Pomegranate (Punica granatum) peel is effective in a murine model of experimental Cryptosporidium parvum.

  2012cites this paper
• Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination.

  2012cites this paper
• Development and Validation of a Simple and Rapid UV Spectrophotometric Method for Assay of Nitazoxanide in Pharmaceutical Dosage Forms

  2012cites this paper
• Nitazoxanide

  2012cites this paper
• Cystic echinococcosis is a zoonotic infection caused by the larval stage (metacestode) of Echinococcus granulosus

  2011cites this paper
• Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide.

  2011cites this paper
• In Vitro Susceptibility Testing of Dientamoeba fragilis

  2011cites this paper
• Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review.

  2011cites this paper
• How were new medicines discovered?

  2011cites this paper
• Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication.

  2011cites this paper
• Simultaneous Spectrophotometric Estimation of Nitazoxanide and Ofloxacin in Tablets

  2011cites this paper
• In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani

  2010cites this paper
• PARASITOSES INTESTINAIS: UMA REVISÃO SOBRE SEUS ASPECTOS SOCIAIS, EPIDEMIOLÓGICOS, CLÍNICOS E TERAPÊUTICOS Intestinal parasitic diseases: a review of social, epidemiologic, clinical and therapeutic aspects

  2010cites this paper
• Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.

  2010cites this paper
• Pharmacotherapy of helminth infection.

  2009cites this paper
• Pharmacotherapy of helminth infection

  2009cites this paper
• Pharmacotherapy of helminth infection

  2009cites this paper
• Thiazolides: a new class of antiviral drugs

  2009cites this paper
• Anthelminthic treatment: an adjuvant therapeutic strategy against Echinococcus granulosus.

  2009cites this paper
• Epidemiología de himenolepiosis y otras parasitosis intestinales en una comunidad suburbana de Escuque, Trujillo-Venezuela

  2008cites this paper
• Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide.

  2008cites this paper
• 9 and Chemotherapy

  2008cites this paper
• Rapid determination of nitazoxanide in tablets using reversed-phase ultra-performance liquid chromatography (UPLC) and high-performance liquid chromatography.

  2008cites this paper
• Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.

  2008cites this paper
• Thiazolides inhibit growth and induce glutathione‐S‐transferase Pi (GSTP1)‐dependent cell death in human colon cancer cells

  2008cites this paper
• Cryptosporidium parvum: enhancing our understanding of its unique fatty acid metabolism and the elucidation of putative new inhibitors

  2008cites this paper
• Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides.

  2008cites this paper
• A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides

  2007cites this paper
• Pathogenesis and disease

  2007cites this paper
• Prophylaxis and chemotherapy.

  2007cites this paper
• Bioequivalence Study of a Fixed Dose Combination of Nitazoxanide and Ofloxacin in Indian Healthy Volunteers

  2007cites this paper
• Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent.

  2007cites this paper
• Toxoplasma as a Model System for Apicomplexan Drug Discovery

  2007cites this paper
• Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections

  2006cites this paper
• An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease.

  2006cites this paper
• Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH).

  2006cites this paper
• Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.

  2006cites this paper
• Identification of isoflavone derivatives as effective anticryptosporidial agents in vitro and in vivo.

  2006cites this paper
• In Vitro Activities of Itraconazole, Methiazole, and Nitazoxanide versus Echinococcus multilocularis Larvae

  2006cites this paper
• In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells

  2006cites this paper
• Nitazoxanide: a new thiazolide antiparasitic agent.

  2005cites this paper
• In Vitro Efficacies of Nitazoxanide and Other Thiazolides against Neospora caninum Tachyzoites Reveal Antiparasitic Activity Independent of the Nitro Group

  2005cites this paper
• Nitazoxanide.

  2005cites this paper
• Treatment of Clostridium difficile-associated disease: old therapies and new strategies.

  2005cites this paper
• Evaluacin de la nitazoxanida en dosis nica y por tres das en parasitosis intestinal

  2004cites this paper